| Term 
 
        | CNS stimulants principal uses
 |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | amphetamine, dextroamphatamine, methamphetamine, lisdexamfetamine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Act causing release of NE and DA, and partly by inhibiting reuptake of both. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Increase wakefulness & alertness, reduced fatigue,euphoria, talkative, increase motor activity, elevate mood, augment self-confidence and intiative, stimulate respirations, supress appetite and perception of pain. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Secondary to NE. increased HR, AV conduction, and force of contraction. Vasoconstrict bl. vessels, dysrhuthmias, HTN. |  | 
        |  | 
        
        | Term 
 
        | Amphetamines tolerance & dependence
 |  | Definition 
 
        | Regular use causes tolerance to elevation of mood, suppression of appetite, and stimulation of the heart and blood vessels. Chronic use causes physical and psychological dependence. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Potential for abuse because of euphoria. |  | 
        |  | 
        
        | Term 
 
        | Amphetamines abstinence syndrome on DC
 |  | Definition 
 
        | Exhaustion, depression, prolonged sleep, excessive sleep, excessive eating, craving amphetamine |  | 
        |  | 
        
        | Term 
 
        | Amphetamines adverse effects
 |  | Definition 
 
        | insomnia,restless, extreme loquaciousness, weight loss, CV effects, psychosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dizzy, confused, hallucination, paranoid delusions, palpitations, dysrhythmias, HTN, convulsions, coma, cerebral hemorrhage, death TX-chlorpromazine, phentolamine, diazepam, acidify urine
 |  | 
        |  | 
        
        | Term 
 
        | methylphenidate & dexmethylphenidate MOA
 |  | Definition 
 
        | Pharmacologic actions same as amphetamines. Promote NE and DA release and inhibit NE and DA reuptake
 |  | 
        |  | 
        
        | Term 
 
        | methylphenidate & dexmethylphenidate side effects
 |  | Definition 
 
        | insomnia, reduced appetite/wt. loss, emotional lability, stomach ache, HA, rebound symptoms, irritable/jittery, dysphoric, zombi-like, tics/abnormal movement, HTN, hallucinations, growth suppression |  | 
        |  | 
        
        | Term 
 
        | methylphenidate & dexmethylphenidate Efficacy in tx ADHD
 |  | Definition 
 
        | Improve attentiveness & academic performance, behavior, impulse control, and peer relations while decreasing aggressive behavior. Long-term:no significant improvements
 |  | 
        |  | 
        
        | Term 
 
        | methylphenidate & dexmethylphenidate abuse
 |  | Definition 
 
        | Can cause euphoria. Drug diversion |  | 
        |  | 
        
        | Term 
 
        | methylphenidate & dexmethylphenidate drug interactions
 |  | Definition 
 
        | psychostimulants, MAOIs, theophylinne, antidepressants, anticonvulsants, coumadin |  | 
        |  | 
        
        | Term 
 
        | methylphenidate & dexmethylphenidate dosing/length of therapy in ADHD
 |  | Definition 
 
        | Individualized. Titrate to max efficacy w/min side effects. May attempt DC at one yr intervals, but many do not outgrow disease |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | chocolate, dessert, soft drink, and beverages from natural products (coffe, tea cola). |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blockade of adenosine receptors.Vasodilate periphery, vasoconstrict CNS, relax bronchial smooth muscle, diuretic, crosses placenta. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | low dose-Decreases fatigue, increases capacity for prollonged intellectual exertion, dec # & duration apnea episodes, promote reg pattern breathing in neonates.Increased doses-insomnia, nervous, tremors. High dose-convulsions |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | narcolepsy, shift-work sleep disorder, sleep apnea, fatigue, depression, ADHD, jet lag, drug induced sleepiness, MS fatigue |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Influence hypothalamic area of sleep-wake cycle inhibitors activit of sleep-promoting neurons, block reuptake NE |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HA, nausea, nervous, diarrhea, rhinitis, increase HR & BP, euphoria, altered perception/thinking/feeling, terotogenic, Steven-Johnsons, erythema multiforme,toxic epidermal necolysis |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | related to Provigil-only difference is longer 1/2 life |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | No medical purpose/rat poison. S/S early-pt fully conscious, stiffness in muscles of face & neck,tonic convulsions, increase reflex excitability. Late-convulsions alternate with depression episodes until death |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Neuropsych disorder of childhood. Possible DA & NE implications. Start 3-7y/o and persists into adulthood. Boys>girls |  | 
        |  | 
        
        | Term 
 
        | ADHD characteristics in childhood
 |  | Definition 
 
        | Inattention-(off task, easily distract, incompletion of tasks) Hyperactivity-(excessive movements)
 Impulsivity-(act before think,changing activities often, disorganized, impatient)
 |  | 
        |  | 
        
        | Term 
 
        | ADHD Coorelation w/development
 |  | Definition 
 
        | genetics, fetal alcohol, low birth weight, head trauma, lead exposure, meningitis |  | 
        |  | 
        
        | Term 
 
        | ADHD management in children
 |  | Definition 
 
        | 1st line-stimulant drugs (2ndnonstimulants) family therapy
 parent training
 cognitive therapy for child
 collaboration of clinician, family, and educators
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Improved relationships -Decreased frequency in disruptive bx
 -Improved quality, efficiency, and quantity of completed school work
 -Increased independence in self-care and age appropriate activities
 -Improved self-esteem
 -Enhanced safety
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anxiety, depression, Bipolar, Tourette's, substance abuse |  | 
        |  | 
        
        | Term 
 
        | ADHD classroom interventions
 |  | Definition 
 
        | Seated near teacher Staff to review daily assignments
 physical exercise
 |  | 
        |  | 
        
        | Term 
 
        | ADHD characteristic in adulthood
 |  | Definition 
 
        | Poor concentration, stress intolerance, antisocial behavior,anger outbursts, inability to maintain routines. |  | 
        |  | 
        
        | Term 
 
        | ADHD consequences untreated adulthood
 |  | Definition 
 
        | Job loss, divorce, driving accidents |  | 
        |  | 
        
        | Term 
 
        | ADHD management in adulthood
 |  | Definition 
 
        | 1st line-Stimulant drug 1/3 can not tolerate-nonstilmulant after failed stimulant attempt.
 Combo with behavioral therapy
 |  | 
        |  | 
        
        | Term 
 
        | ADHD CNS stimulants drug therapy
 list
 |  | Definition 
 
        | methylphenidate, dextroamphetamine, mixed amphetamines, methylphenidate |  | 
        |  | 
        
        | Term 
 
        | ADHD CNS stimulants disadvantages
 |  | Definition 
 
        | Have to see physician q month Abuse potential
 Responses tend to diminish after 2-3yr
 Reduce NEGATIVE behavior, do not create positive behavior
 |  | 
        |  | 
        
        | Term 
 
        | ADHD non-stiumulant drugs
 list
 |  | Definition 
 
        | Strattera, guanfacine, clonidine |  | 
        |  | 
        
        | Term 
 
        | Srattera therapeutic effects
 |  | Definition 
 
        | Reduces symptoms, max response takes 1-3wks |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Selective inhibitor of NE reuptake, causing NE to accumulate at synapses |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | metabolized in P450 system, daily or BID dose |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dyspepsia, N/V, reduced appetite, dizzy,anorexia, FATIGUE, SEDATION, somnolence, mood swings, trouble sleeping, sexual dysfunction, urinary retention, allergic reactions, suicidal thinking, appetite suppression resulting in wt. loss and growth retardation, liver injury, raise or lower BP, tachycardia |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | guanfacine use & side effects in ADHD
 |  | Definition 
 
        | Adjunct to reduce aggression -somnolence, fatigue, reduced BP(most pronounced initial therapy), wt. gain
 |  | 
        |  | 
        
        | Term 
 
        | clonidine use & side effects in ADHD
 |  | Definition 
 
        | Adjunct to reduce aggression and aide in sleep -somnolence, fatigue, hypotension, slow HR (increased by use of othe CNS depressants), heart block, dizzy, constipation
 |  | 
        |  | 
        
        | Term 
 
        | Risperdal,Zyprexa,Geodon use & side effects in ADHD
 |  | Definition 
 
        | Control severe aggression Improve hyperactivity and impulsivity
 Beneficial is concurrent ODD/bipolar
 -EPS, dizzy, hepatotoxic, wt. gain, increased prolactin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Short term for severe aggression |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | methylphenidate patch. applied 9hr, heat increases absorption |  | 
        |  |